5. Sensitivity analysis ‐ radiotherapy use.
| Outcome | All studies | Only studies using radiotherapy |
| 6‐month survival | NSSD | NSSD |
| 12‐month survival | NSSD | NSSD |
| 24‐month survival | NSSD | NSSD |
| Overall response | NSSD | NSSD |
| Complete response | P | P |
| Toxic death | NSSD | NSSD |
| Nausea and Vomiting | NP | NP |
| Alopecia | NSSD | NSSD |
| Infection | NSSD | NSSD |
| Anaemia | NSSD | NSSD |
| Leukopenia | NSSD | NSSD |
| Thrombocytopenia | NP | NP |
| Granulocytopenia | NSSD | NSSD |
NSSD ‐ No statistically significant difference between treatment groups.
P ‐ Statistically significant effect favouring platinum‐based regimens.
NP ‐ Statistically significant effect favouring non‐platinum‐based regimens.